Contact: Emily Passer [email protected] Data & methodology Weight loss and engagement: January 2026 analysis of 14,203 Noom GLP-1 Rx Program members who started a GLP-1 Rx plan between December 2024 and February 2025 and logged weight during a measurement week (4, 8, 16, 40 weeks)
Take control of your health journey contact us today
Supports mitochondrial health and cellular energy by promoting efficient energy metabolism and antioxidant activity
The FDA's 503A Bulks List identifies bulk drug substances that may be used by licensed 503A compounding pharmacies in preparing customized medications for individual patients pursuant to a valid prescription, subject to applicable statutory and regulatory requirements
In Australia (and the United States), Ozempic is approved for use to improve blood glucose levels in adults with type 2 diabetes
This product is manufactured in Enivas NSF Certified Facility Supports cardiovascular health, brain health and mental function, immune health & energy metabolism.